Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among Patients with NSCLC and the Risk of Death From Any Cause Among Patients with Solid Tumours By Ogkologos - May 7, 2025 554 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the analysis of TRACERx and MSK-IMPACT studies Source RELATED ARTICLESMORE FROM AUTHOR Postneoadjuvant Trastuzumab Deruxtecan Results in Higher Likelihood of iDFS Among Patients with HER2-positive EBC with Residual Invasive Disease After Neoadjuvant Treatment Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate and Longer PFS in Patients with Relapsed or Refractory Follicular Lymphoma Patient Guide in Prostate Cancer Now Available in Vietnamese MOST POPULAR How clues from crystals might help us prevent the overtreatment of... June 20, 2023 2020 round-up: Our biggest cancer stories of the year December 20, 2020 Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App September 18, 2021 Vepdegestrant Results in Longer PFS Than Fulvestrant in Previously Treated Patients... June 4, 2025 Load more HOT NEWS Investing in volunteers since 2002: The tale of time Cancer in My Community: Working Toward Early Diagnosis for Children With... Adjuvant Pembrolizumab Improves Overall Survival Among Patients with Clear-Cell Renal Cell... Marine Runs Five Marathons in Five Days to Help Fund Sister’s...
